Coherent (COHR) files Form 144 to sell 2,000 shares ($233K)
Coherent Corp. (COHR) filed a Form 144 notifying a proposed sale of 2,000 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $233,120.00.
Rhea-AI Filing Summary
Coherent Corp. (COHR) filed a Form 144 notifying a proposed sale of 2,000 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $233,120.00. The shares are listed on the NYSE and the filing shows an approximate sale date of 08/13/2025. The issuer's total outstanding shares are reported as 155,440,611, providing context for the size of this proposed sale.
The securities to be sold were acquired as Restricted Stock Units from the issuer on 07/05/2022. The filer reports Nothing to Report for sales in the past three months. The form also includes the standard representation that the person signing the notice does not know any undisclosed material adverse information about the issuer.
Positive
- None.
Negative
- None.
Insights
TL;DR: Small, routine insider sale notice of 2,000 RSU-derived shares via an institutional broker; unlikely to be market-moving.
The Form 144 documents a proposed sale of 2,000 common shares with an aggregate market value of $233,120 through Morgan Stanley Smith Barney LLC on the NYSE. The shares were acquired as restricted stock units on 07/05/2022. Given the issuer's reported outstanding share count of 155,440,611, the scale of the proposed sale is immaterial to capitalization. The filing also states there were no sales by the person in the prior three months. This appears to be a routine liquidity event rather than a material corporate development.
TL;DR: Compliance-focused disclosure consistent with Rule 144; shows use of an established broker and standard seller representations.
The notice follows Rule 144 disclosure conventions, identifying the broker, the class of securities, and acquisition details (RSUs dated 07/05/2022). The filing includes the typical attestation that the seller is not aware of undisclosed material adverse information. There are no reported sales in the prior three months, and no additional governance or control changes are indicated. From a governance perspective, the document is procedural and does not signal corporate governance risk or change.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Coherent (COHR) file in this Form 144?
Who is the broker handling the proposed COHR sale?
How were the securities to be sold acquired?
Has the filer sold COHR securities in the past three months?
AI-generated analysis. How Rhea-AI works. Not financial advice.